Fatal Eastern Equine encephalitis in a patient on maintenance Rituximab: A case report

17Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 63-year-old woman on rituximab maintenance for follicular lymphoma presented with headaches, vomiting, and fever, and was diagnosed with eastern equine encephalomyelitis by cerebrospinal fluid polymerase chain reaction. Eastern equine encephalomyelitis immunoglobulin (Ig)G/IgM remained negative due to rituximab treatment, and magnetic resonance imaging showed minimal abnormalities, making this a diagnostically challenging case. Despite therapy with intravenous Ig, the patient rapidly declined and died on hospital day 12. Autopsy revealed perivascular and parenchymal chronic inflammation, with an absence of B lymphocytes, and virally infected neurons throughout the central nervous system.

Cite

CITATION STYLE

APA

Solomon, I. H., Ciarlini, P. D. S. C., Santagata, S., Ahmed, A. A., De Girolami, U., Prasad, S., & Mukerji, S. S. (2017). Fatal Eastern Equine encephalitis in a patient on maintenance Rituximab: A case report. Open Forum Infectious Diseases, 4(1). https://doi.org/10.1093/OFID/OFX021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free